Skip to main content
Caplight Logo









Metyos

Metyos

Private
ParisHealthcare & Life Scienceshttps://www.metyos.com/

Last Round

Pre Seed

Mar 26, 2024

Total Funding Raised

$4.99M

Company Overview

Metyos is a medtech company that develops a biowearable sensor and disease management platform for continuous monitoring of patients with chronic kidney disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

remote patient monitoringRPMbiowearablewearable biosensorchronic kidney diseaseCKDmicroneedle arraydigital healthmedtechcontinuous monitoringclinical decision supporthealth IoTconnected healthremote carepatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Metyos Comparables

Compare Metyos with similar companies based on industry and business-model similarity.

Metyos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proton Intelligence
91%
KitechDx
91%
Kalium Health
88%

Metyos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 26, 2024
Pre SeedMar 26, 2024

Key People

Founding team and executive leadership

Olga Chashchina

Co-founder And CTO

Founding Team

Alexandre Boulanger

Co-Founder CEO

Founding Team

Metyos Investors

Notable investors and investment history

Metyos investors
InvestorRounds
Kima VenturesPre Seed
Advans LabPre Seed
BpifrancePre Seed
CenitzPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2024

    $2.5M round led by Cenitz

Metyos Filings

Explore SEC and related filing metadata, where available.

Metyos filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Metyos's valuation, stock price, and market status.

Is Metyos a public or private company?

Metyos is a private company.

What is the current stock price of Metyos?

Metyos is a private company with no public stock price. No recent secondary market data is available.

How much is Metyos worth (valuation)?

Valuation information for Metyos is not publicly available.

Can I buy Metyos stock?

Metyos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Metyos's last funding round?

Metyos's most recent funding round was Pre Seed on March 26, 2024.

Who are the main investors in Metyos?

Key investors in Metyos include Cenitz.

Will Metyos IPO soon?

No public IPO plans have been announced for Metyos.

How can I track Metyos secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Metyos's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range12
Year Founded2021
Last FundingMar 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?